Document is current
Any future updates will be listed below
-
Authors
Cipolletta, Edoardo https://orcid.org/0000-0002-6881-8197
Francioso, Francesca
Smerilli, Gianluca https://orcid.org/0000-0002-3972-4458
Di Battista, Jacopo
Filippucci, Emilio https://orcid.org/0000-0002-7251-7784
- License Information
-
More Information
Article History
Received: 2 September 2023
Revised: 24 October 2023
Accepted: 28 October 2023
First Online: 17 November 2023
Declarations
:
: E.F. has received speaking fees from AbbVie, Bristol-Myers Squibb, Celgene, Novartis, Pfizer, Roche, and Union Chimique Belge Pharma outside the submitted work.All other authors have declared no conflict of interest.
